Funding Details
- Awarder
- Inbox
- Date Award
- May 06, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$45,000,000
Company Info
- Traction
- Nuevocor is advancing NVC-001 into a first-in-human, open-label, multicenter, ascending single-dose Phase 1/2 clinical trial.
- Founders
- Dr. Yann Chong Tan
- Company Description
- Nuevocor operates as a preclinical-stage biotech company.
- Market
- Cardiovascular disease
- Location
-
Singapore
- Coinvestors
- Kurma Partners, Angelini Ventures, EDBI, ClavystBio, Boehringer Ingelheim Venture Fund, Highlight Capital, SEEDS Capital
Links